worldwiki
Product · Plastic Surgery

Breast Implant

Also known as: 보형물, 가슴 보형물

Published Sep 14, 2026Updated Nov 12, 2026
Requests recorded in this site’s own server logs, with the crawler identity checked by reverse DNS or IP range.Meta77OpenAI32Google24Ahrefs6Microsoft2Anthropic1Apple1Perplexity1First collected Sep 15, 2026Recent requestsOpenAINov 5, 2026MicrosoftNov 3, 2026MicrosoftOct 30, 2026OpenAIOct 28, 2026AhrefsOct 27, 2026AhrefsOct 25, 2026AhrefsOct 25, 2026AhrefsOct 24, 2026AhrefsOct 20, 2026Meta · unverifiedOct 12, 2026Meta · unverifiedOct 12, 2026Meta · unverifiedOct 12, 2026
Request a correction
Definition

A breast implant is a silicone-shell medical device filled with silicone gel or saline that is placed to enlarge or reconstruct the breast.

Quick answer

가슴 보형물은 몇 년마다 교체해야 하나요?

정해진 교체 주기는 없습니다. FDA는 보형물이 평생 쓰는 기기가 아니어서 누구나 추가 수술이 필요할 수 있지만, 그 시기는 예측할 수 없다고 안내합니다. 교체 여부는 구형구축, 파열, 모양 변화 같은 문제가 생겼는지와 정기 영상검사 결과를 보고 의료진과 함께 판단합니다. 식약처는 수술 후 5~6년째에 첫 영상검사를 받고, 이후 2~3년마다 검사받을 것을 권고합니다.

Verified Sep 18, 2026

Key facts

PredicateValueSource
US FDA-approved types and age limitsSaline-filled and silicone gel-filled implants are FDA-approved. For breast enlargement, saline requires age 18 or older and silicone gel requires age 22 or older. For reconstruction, both are approved at any age.as of Oct 23, 2019[2]governmentTypes of Breast ImplantsU.S. Food and Drug Administration
Expected lifespanNot a lifetime device. The longer implants are in place, the more likely they are to need removal or replacement.as of Mar 8, 2023[3]governmentThings to Consider Before Getting Breast ImplantsU.S. Food and Drug Administration
Detecting silent rupture (silicone gel)MRI is the most effective method. Ultrasound is an acceptable alternative for screening patients without symptoms.as of Dec 14, 2023[4]governmentRisks and Complications of Breast ImplantsU.S. Food and Drug Administration
US labeling guidanceFinal FDA guidance issued September 2020 (docket FDA-2019-D-4467) on patient labeling content and format, including a boxed warningas of Sep 1, 2020[5]governmentBreast Implants – Certain Labeling Recommendations to Improve Patient Communication (Final Guidance)U.S. Food and Drug Administration
FDA first linked implants to ALCL2011as of Oct 23, 2019[6]governmentQuestions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)U.S. Food and Drug Administration
BIA-ALCL medical device reports to FDA1,380 reports (US and non-US), including 64 deaths. Median time to diagnosis was 8 years after implantation. reportsas of Jun 30, 2024[7]governmentMedical Device Reports of Breast Implant-Associated Anaplastic Large Cell LymphomaU.S. Food and Drug Administration
BIA-ALCL reports by implant surfaceTextured 1,010 (73%); smooth 40 (3%, only one with no known history of textured implants); not specified 330 (24%) reportsas of Jun 30, 2024[7]governmentMedical Device Reports of Breast Implant-Associated Anaplastic Large Cell LymphomaU.S. Food and Drug Administration
Notable recallIn 2019 the FDA asked Allergan to voluntarily recall its Natrelle BIOCELL textured breast implantsas of Dec 15, 2023[8]governmentBreast ImplantsU.S. Food and Drug Administration
South Korea (MFDS) classificationSilicone gel breast implants (실리콘겔인공유방) are Class 4 devices that must be tracked (추적관리대상). Providers must keep records of the patient, device serial number, implantation date and facility.[9]government추적관리대상 의료기기 안내 (의료기기전자민원시스템)Ministry of Food and Drug Safety (Korea)
South Korea BIA-ALCL safety measuresMFDS measures announced 2019-08-28: identify patients with Allergan textured implants, separately register suspected BIA-ALCL cases, and advise annual check-ups starting one year after implantationas of Aug 28, 2019[10]government[안전성정보] 식약처, 유방보형물 이식환자 안전관리 대책 마련식품의약품안전처
Device typeSilicone shell filled with silicone gel or saline; regulated medical device[1]governmentBreast enlargement (implants)NHS (UK National Health Service)
Known risksRupture, capsular contracture, need for imaging adaptations, possible replacement[1]governmentBreast enlargement (implants)NHS (UK National Health Service)

Overview

A breast implant is a medical device placed by surgery. It is a silicone shell filled with saline or silicone gel. It is used to enlarge the breasts, to rebuild a breast after mastectomy, or to replace an earlier implant. Products differ in fill material, size, shape and surface texture (smooth or textured). In the United States, the FDA has approved saline-filled and silicone gel-filled implants and sets minimum ages for cosmetic use. In South Korea, silicone gel implants are Class 4 (highest-risk) devices that must be tracked. Regulators state that implants are not lifetime devices. Reported problems include rupture, which may cause no symptoms and is best found with MRI; capsular contracture; BIA-ALCL, a rare immune-system cancer linked more often to textured implants; and body-wide symptoms that are poorly understood. Readers should check the specific product's approval status, surface type, patient labeling and recommended imaging follow-up.

Evidence & claims

Official claims are statements by the provider; they are not verified by worldwiki unless marked otherwise.
ClaimTypeEvidenceSource
Breast implants are not lifetime devices and may require replacement.riskhighBreast enlargement (implants)

References

Independent source ratio 100% (10/10)
Level A · 10
  1. Level A · governmentBreast enlargement (implants) — NHS (UK National Health Service) · accessed Nov 12, 2026 · Evidence page
  2. Level A · governmentTypes of Breast Implants — U.S. Food and Drug Administration · accessed Nov 12, 2026 · Evidence page
  3. Level A · governmentThings to Consider Before Getting Breast Implants — U.S. Food and Drug Administration · accessed Nov 10, 2026 · Evidence page
  4. Level A · governmentRisks and Complications of Breast Implants — U.S. Food and Drug Administration · accessed Nov 12, 2026 · Evidence page
  5. Level A · governmentBreast Implants – Certain Labeling Recommendations to Improve Patient Communication (Final Guidance) — U.S. Food and Drug Administration · accessed Nov 10, 2026 · Evidence page
  6. Level A · governmentQuestions and Answers about Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) — U.S. Food and Drug Administration · accessed Nov 12, 2026 · Evidence page
  7. Level A · governmentMedical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma — U.S. Food and Drug Administration · accessed Nov 12, 2026 · Evidence page
  8. Level A · governmentBreast Implants — U.S. Food and Drug Administration · accessed Nov 12, 2026 · Evidence page
  9. Level A · government추적관리대상 의료기기 안내 (의료기기전자민원시스템) — Ministry of Food and Drug Safety (Korea) · accessed Nov 10, 2026 · Evidence page
  10. Level A · government[안전성정보] 식약처, 유방보형물 이식환자 안전관리 대책 마련 — 식품의약품안전처 · accessed Nov 12, 2026 · Evidence page
Change history
Initial publication · Sep 14, 2026